Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSXV/ZYUS stock hub

TSXV/ZYUS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/ZYUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

39.9M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/ZYUS

In the news

Latest news · TSXV/ZYUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-3,516.8

P25 -121.5P50 -40.9P75 0.5

ROIC-73.6

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/ZYUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

CAD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 54.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	CAD 39.9M
Price	CAD 0.5
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/ZYUS
Website	https://www.zyus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-84.66%
EV Earnings	-1.62x
EV/FCF	-5.09x
EV/Sales	117.52x
FCF yield	-26.94%
P/B ratio	-3.07x
P/S ratio	85.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-220.86%
Gross Profit	CAD -1M
Net Income	CAD -33.7M
Pretax Margin	-7,694.84%
ROA	-41.04
ROCE	304.2
ROE	-3,516.8
ROIC	-73.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-32.21%
Revenue Growth	2.88x
Revenue Growth Q	-14.63x
Revenue Growth3 Y	17.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.02
Assets	CAD 10.8M
Cash	CAD 361,000
Current Assets	CAD 1.6M
Current Liabilities	CAD 15.7M
Debt	CAD 15.2M
Debt FCF	CAD -1.41
Equity	CAD -13M
Interest Coverage	-9.29
Liabilities	CAD 23.8M
Long Term Assets	CAD 9.3M
Long Term Liabilities	CAD 8.1M
Net Cash	CAD -14.8M
Net Cash By Market Cap	CAD -37.11
Tangible Book Value	CAD -13M
Tangible Book Value Per Share	CAD -0.17
WACC	7.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.1
Inventory Turnover	1.24
Net Working Capital	CAD -7.4M
Quick ratio	0.05
Working Capital	CAD -14.1M
Working Capital Turnover	CAD -0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-32.19%
200-day SMA	0.67
50-day SMA	0.58
50-day SMA vs 200-day SMA	50under200
All Time High	1.41
All Time High Change	-64.89%
All Time High Date	2023-07-04
All Time Low	0.4
All Time Low Change	25.32%
All Time Low Date	2026-05-05
ATR	0.05
Beta	0.46
Beta1y	-0.02
Beta2y	0.54
Ch YTD	-29.29
High	0.5
High52	0.87
High52 Date	2025-06-02
High52ch	-43.1%
Low	0.5
Low52	0.4
Low52 Date	2026-05-05
Low52ch	25.32%
Ma50ch	-15.2%
Price vs 200-day SMA	-26.28%
RSI	44.16
RSI Monthly	27.37
RSI Weekly	35.34
Sharpe ratio	-0.42x
Sortino ratio	-0.52
Total Return	-6.48%
Tr YTD	-29.29
Tr1m	-13.16%
Tr1w	23.75%
Tr3m	-23.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -14.7M
Operating margin	-3,165.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,840,235%
Net Borrowing	10,729,000
Shares Insiders	49.28%
Shares Institutions	0.17%
Shares Out	80,522,813
Shares Qo Q	3.07%
Shares Yo Y	6.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -11M
Average Volume	8,940.55x
Bv Per Share	-0.17
CAPEX	CAD -10,000
Ch1m	-13.16
Ch1w	23.75
Ch1y	-32.19
Ch3m	-23.85
Ch6m	-29.29
Change	10%
Change From Open	-1
Close	0.45
Days Gap	11.11
Depreciation Amortization	2,427,000
Dollar Volume	1,495.9
Earnings Date	2026-05-14
EBIT	CAD -14.7M
EBITDA	CAD -12.3M
EPS	CAD -0.45
F Score	3
FCF	CAD -10.7M
FCF EV Yield	-19.65x
FCF Per Share	CAD -0.13
Financing CF	10,729,000
Fiscal Year End	December
Founded	2,018
Income Tax	CAD -2M
Investing CF	15,000
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-09-30
Ma150	0.65
Ma150ch	-23.78%
Ma20	0.54
Ma20ch	-8.47%
Net CF	15,000
Next Earnings Date	2026-05-14
Open	0.5
Position In Range	0
Ppne	9,117,000
Price Date	2026-05-06
Relative Volume	0.34x
Revenue	465,000x
SBC By Revenue	46.02x
Share Based Comp	214,000
Tax By Revenue	-438.06x
Tr6m	-29.29%
Volume	3,022
Z Score	-28.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/ZYUS pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/ZYUS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/ZYUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.2%

Share of float held by funds and institutions

Insider ownership

+49.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.5%

Negative means the company is buying back shares.

Technical

TSXV/ZYUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.2

Neutral momentum band

Price vs 200-day MA

-26.3%

50/200-day relationship not available

Beta (5Y)

0.46

Less volatile than the market

Sharpe ratio

-0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/ZYUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/ZYUS stock rating?

tsxv/ZYUS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/ZYUS analysis?

The full report lives at /stocks/tsxv/ZYUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/ZYUS?

The latest report frames tsxv/ZYUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/ZYUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.